reckless coverage by Dundee
I am actually amazed that someone can get away with printing the uninformed crap that David Martin puts out on Prometic. Its just unbelievable. He clearly has some kind of an axe to grind.
For an MBA PhD, its incredible that he uses such shallow assesment of the situation. He really is doing a disservice to Dundee clients.
DO YOUR DAMN HOMEWORK MARTIN you idiot
If you can combine an oral dose of 1402 with a lower dose of EPO and close to double the effect on reticulocytes with LOWER COST and a potentially expanded patient base in a $10 Billion dollar market.... do you think there potentially may be a little demand for a compound like this amongst big pharma .... ?
Its also quite commonly known that effective Dosages in Healthy trials is considerably different (higher)than Dosages in patient populations.... the fact that he is attributing a "higher risk to developent of the compound" at a time where we have just established a considerably lower risk because of both safety and BETTER than expected efficacy in healthy trials...
ABSOLUTELY UNBELIEVABLE